Northwest Biotherapeutics Inc (OTCQB:NWBO)

0.1895
Delayed Data
As of Apr 20
 +0.0125 / +7.06%
Today’s Change
0.14
Today|||52-Week Range
0.40
-19.44%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Quarter 4
2017
Operating ActivitiesNet Income / Starting Line-12.6M-10.3M-23.3M-27.0M
 
 
 
 
 
Depreciation56.0K44.0K41.0K298.0K
 
 
 
 
 
Total Other Cash Flow469.0K1.1M10.1M16.5M
 
 
 
 
 
Funds From Operations-12.1M-9.1M-13.1M-10.2M
 
 
 
 
 
Funds From/For Other Operating Expenses188.0K-5.4M-7.4M4.6M
 
 
 
 
 
Net Cash Flow - Operating Activities-12.3M-3.7M-5.7M-14.8M
 
 
 
 
 
 
InvestingCapital Expenditures0.00-9.0K-5.0K6.0K
 
 
 
 
Fixed Asset Disposal218.0K2.0K----
 
 
 
Other Investing - Sources0.000.00220.0K0.00
 
 
Net Cash Flow Investing218.0K-7.0K-5.0K6.0K
 
 
 
 
 
 
FinancingShort Term Borrowings-----699.0K-350.0K
 
 
 
Long Term Borrowings3.0M2.5M891.0K4.7M
 
 
 
 
 
Long Term Debt Reduction-1.7M-1.5M0.000.00
 
 
 
Net Proceeds Stock Sale6.7M982.0K7.9M9.9M
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends----------
Cash Dividends Paid - Total0.000.00------
Other Sources - Financing0.000.000.000.00--
Other Uses - Financing0.000.000.000.00--
Net Cash Flow - Financing8.0M3.9M8.1M14.3M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash-622.0K-2.4M-1.3M-441.0K
 
 
 
 
 
 
Net Change In Cash-4.0M151.0K2.4M-493.0K